PRESS RELEASE published on 05/25/2023 at 08:00, 2 years 11 months ago Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
PRESS RELEASE published on 05/15/2023 at 08:00, 2 years 11 months ago Biophytis a demandé à l’EMA l’autorisation de lancer l’étude SARA-31 de phase 3 dans la sarcopénie
PRESS RELEASE published on 05/15/2023 at 08:00, 2 years 11 months ago Biophytis has filed with the EMA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 05/11/2023 at 08:00, 2 years 11 months ago Successful capital increase for Biophytis with €2.3 million raised
PRESS RELEASE published on 05/11/2023 at 08:00, 2 years 11 months ago Succès de l’augmentation de capital de Biophytis avec 2,3 millions d’euros levés
PRESS RELEASE published on 05/10/2023 at 19:05, 2 years 11 months ago Biophytis lance une levée de fonds d’environ 2 millions d’euros
PRESS RELEASE published on 05/10/2023 at 19:05, 2 years 11 months ago Biophytis launches a round of fundraising for approximately 2 million euros
PRESS RELEASE published on 05/09/2023 at 08:00, 2 years 11 months ago Biophytis has requested a pre-submission meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 05/09/2023 at 08:00, 2 years 11 months ago Biophytis a requis auprès de l’EMA une réunion de pré-soumission d’Autorisation de Mise sur le Marché de Sarconeos (BIO101) dans le traitement de la COVID-19
PRESS RELEASE published on 05/02/2023 at 08:00, 3 years ago Biophytis annonce le renforcement de son équipe de Direction
Published on 05/08/2026 at 22:30, 20 minutes ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 20 minutes ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 21:00, 1 hour 50 minutes ago NOA Lithium Receives Biannual Renewal to Rio Grande's Exploration Permits and Provides Corporate Updates
Published on 05/08/2026 at 15:55, 6 hours 55 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 7 hours 50 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 20:38, 2 hours 12 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 3 hours 37 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 3 hours 48 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 3 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 3 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 3 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 3 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 3 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
